New Age Traveler
From Iceland’s volcanic springs to a lab in South Denmark; does the microbe Sulfolobus. islandicus hold the key to a drug’s safe transit through the gut?
The acidic conditions of the human gut pale in comparison to the microbe Sulfolobus islandicus’ 75 °C, pH 2 Nordic abode. Millions of years of evolution in these harsh conditions have given the microbe a resilient lipid exterior – that could potentially be interesting for drug development purposes.
“S. islandicus belong to the Archaea – a domain of single-celled microorganisms – and like all archaea it contains lipids that are stable against premature degradation and thus suited to lipid-based oral drug delivery-systems that are less sensitive to bile salts,” says Martin Brandl, a professor at University of Southern Denmark. He and his colleagues have isolated lipids from the volcanic spring dwelling microbe to construct a nano-capsule that they believe can transport drugs safely through the stomach (1). This feature appears especially promising for the delivery of protein- and peptide-drugs, many of which currently cannot be administered orally due to their inherent instability in the stomach and duodenum.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.